Literature DB >> 9881774

Structural changes in the oligosaccharide moiety of human IgG with aging.

K Shikata1, T Yasuda, F Takeuchi, T Konishi, M Nakata, T Mizuochi.   

Abstract

In order to elucidate the relationship between glycosylation of IgG and aging, oligosaccharide structures of human IgG purified from sera of men and women aged 18 to 73 years were investigated. Oligosaccharides were liberated quantitatively from IgG by hydrazinolysis followed by N-acetylation and were tagged with p-aminobenzoic acid ethyl ester. The oligosaccharide structures were then analyzed by HPLC in conjunction with sequential exoglycosidase digestion. All IgG samples were shown to contain a series of biantennary complex type oligosaccharides which consisted of +/-Galbeta1-4GlcNAcbeta1-2Manalpha1-6(+/-GlcNAcbeta 1-4)(+/-Galbeta1-4GlcNAcbeta1-2Man(alpha)1-3)Man(beta)1-+ ++4GlcNAcbeta1-4(+/- Fucalpha1-6)GlcNAc and their mono- and disialo glycoforms in different ratios. In female IgG samples only, the incidence of non-galactosylated oligosaccharides with non-reducing terminal GlcNAc residues increased with aging (r>0.8), whereas that of digalactosylated oligosaccharides decreased (r<-0.8). A weaker correlation was observed between aging and the incidence of neutral and monosialo oligosaccharides in female IgG (r=0.461 and r= -0.538, respectively) and between aging and the incidence of oligosaccharides with a bisecting GlcNAc in both male and female IgG samples (r=0.566 and r=0.440, respectively). In addition, a significant change with aging in the galactosylation of IgG oligosaccharides was observed in females in their thirties, fifties, and sixties (p<0.02, p<0.01, and p<0.04, respectively). These findings may contribute to our understanding of autoimmune diseases such as rheumatoid arthritis in which glycosylation is involved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881774     DOI: 10.1023/a:1006936431276

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  24 in total

1.  Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man.

Authors:  R A Childs; K Drickamer; T Kawasaki; S Thiel; T Mizuochi; T Feizi
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures.

Authors:  T Matsui; K Titani; T Mizuochi
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Age related changes in the in vitro immune response: increased suppressor activity in immature and aged mice.

Authors:  R H DeKruyff; Y T Kim; G W Siskind; M E Weksler
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

5.  The age-associated increase in autoreactive immunoglobulins reflects a quantitative increase in specificities detectable at lower concentrations in young mice.

Authors:  A Nobrega; M Haury; R Gueret; A Coutinho; M E Weksler
Journal:  Scand J Immunol       Date:  1996-11       Impact factor: 3.487

6.  Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression.

Authors:  B Heyman; M Nose; W O Weigle
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

7.  Structures of the sugar chains of mouse immunoglobulin G.

Authors:  T Mizuochi; J Hamako; K Titani
Journal:  Arch Biochem Biophys       Date:  1987-09       Impact factor: 4.013

8.  Agalactosyl glycoforms of IgG autoantibodies are pathogenic.

Authors:  T W Rademacher; P Williams; R A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

9.  Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity.

Authors:  R B Parekh; I M Roitt; D A Isenberg; R A Dwek; B M Ansell; T W Rademacher
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

10.  Age-related galactosylation of the N-linked oligosaccharides of human serum IgG.

Authors:  R Parekh; I Roitt; D Isenberg; R Dwek; T Rademacher
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  35 in total

Review 1.  The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.

Authors:  Sybille Böhm; Inessa Schwab; Anja Lux; Falk Nimmerjahn
Journal:  Semin Immunopathol       Date:  2012-03-22       Impact factor: 9.623

2.  Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.

Authors:  Altan Ercan; Jing Cui; Dereck E W Chatterton; Kevin D Deane; Melissa M Hazen; William Brintnell; Colin I O'Donnell; Lezlie A Derber; Michael E Weinblatt; Nancy A Shadick; David A Bell; Ewa Cairns; Daniel H Solomon; V Michael Holers; Pauline M Rudd; David M Lee
Journal:  Arthritis Rheum       Date:  2010-08

Review 3.  Regulation of antibody effector functions through IgG Fc N-glycosylation.

Authors:  Isaak Quast; Benjamin Peschke; Jan D Lünemann
Journal:  Cell Mol Life Sci       Date:  2016-09-17       Impact factor: 9.261

Review 4.  Fc glycan-modulated immunoglobulin G effector functions.

Authors:  Isaak Quast; Jan D Lünemann
Journal:  J Clin Immunol       Date:  2014-04-24       Impact factor: 8.317

5.  Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.

Authors:  Zelda Euler; Galit Alter
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

6.  The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer.

Authors:  L Renee Ruhaak; Donald A Barkauskas; Javier Torres; Cara L Cooke; Lauren D Wu; Carol Stroble; Sureyya Ozcan; Cynthia C Williams; Margarita Camorlinga; David M Rocke; Carlito B Lebrilla; Jay V Solnick
Journal:  EuPA Open Proteom       Date:  2015-03-01

7.  The history of IgG glycosylation and where we are now.

Authors:  Brian A Cobb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

Review 8.  Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

Authors:  Michaela Seeling; Christin Brückner; Falk Nimmerjahn
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

9.  Hypogalactosylation of serum IgG in patients with coeliac disease.

Authors:  J A Cremata; L Sorell; R Montesino; R Garcia; M Mata; G Cabrera; J A Galvan; G Garcia; R Valdes; J A Garrote
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

10.  Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency.

Authors:  Jeremy G Schenkein; Saeyoung Park; Moon H Nahm
Journal:  Vaccine       Date:  2008-08-13       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.